FDA Adverse Event Malfunction Summary report: N

OMNI PRO ACCEPT

MDR report key: 3303893 · Received July 29, 2013

Report

Report Number
9614952-2013-00001
Event Type
Malfunction
Date Received
July 29, 2013
Date of Event
February 27, 2013
Report Date
July 22, 2013
Manufacturer
IBA DOSIMETRY GMBH
Product Code
IYE
PMA / PMN Number
K011763
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

FIRST EVAL OF THE COMPLAINT LEAD TO AN ACCEPTABLE RISK LEVEL WHERE NO ADDITIONAL MEASURES WERE NEEDED BUT IBA DECIDED TO FURTHER INVESTIGATE WITH EXPERT REVIEW FROM R AND D DEPARTMENT. SECOND EVAL WITH R AND D WAS LEADING TO A NEW RISK CLASSIFICATION DIFFERENT FROM THE INITIAL ASSUMPTION AS DONE WHEN RECEIVING THE COMPLAINT. NEW EVAL OF THE COMPLAINT SHOWED THAT REPORTED PROBLEM COULD LEAD TO A SERIOUS INJURY IF IT WOULD NOT BE IDENTIFIED, ESPECIALLY WHEN A TREATMENT PLANNING SYSTEM (TPS) WITH DYNAMIC WEDGES IS COMMISSIONED. THE TREATMENT PANNING SYSTEM WOULD CALCULATE WRONG DOSE DUE TO POSSIBLE MIRRORED DATA, MEASURED WITH OMNIPRO ACCEPT 7.4A. THERE IS A REMOTE PROBABILITY THAT THE PHYSICIST WOULD NOT RECOGNIZE THE COMMISSIONING FAILURE. INTERNAL DETAILED ROOT CAUSE ANALYSIS WAS FINALIZED IN (B)(4) 2013. ROOT CAUSE OF THE PROBLEM IS A FAILURE IN THE SOFTWARE. THE RESAMPLING METHOD, EXECUTED FOR THE SCALED DATA MEASURED WITHOUT REFERENCE, COULD DETERMINE AND USE THE WRONG ORIENTATION TO COPY THE INTERPOLATED VALUES TO THE RESULT BUFFER. THIS IS DEPENDING ON THE WATER PHANTOM ORIENTATION AND THE SCANNING DIRECTION. REPORTED MALFUNCTION OF THE MEDICAL DEVICE IS A REPRODUCIBLE FAILURE IN THE SOFTWARE. NEW SOFTWARE RELEASE IS PLANNED FOR (B)(4) 2013.

Description of Event or Problem · 1

CUSTOMER REPORTED THAT WHEN HE USED THE RESAMPLING FUNCTION OF OMNIPRO ACCEPT 7.4A FOR THE SCANS WITHOUT REFERENCE CHAMBER THE RESAMPLED X- AND Y- CURVES ARE MIRRORED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
354773 OMNI PRO ACCEPT GENERAL DOSIMETRY SYSTEM IYE IBA DOSIMETRY GMBH

Patients

Seq Age Sex Outcome Treatment
1